Innovation in every drop
AI-optimized cell media. Proven to outperform competitors, now powering the future of cell therapy.
Our Approach
Cell culture media hasn't kept pace with cell specific needs. Conventional media is generic and tests only a few ingredients at a time, leaving cells immature and therapies stuck in the lab. boutIQ's AI/ML platform, HiDiNeu, designs optimal formulations for any cell type, from heart cells to T-cells, faster and at a fraction of the cost compared to traditional methods.
Our Organization
University of Toronto-born. Research-backed. Commercially-proven.
boutIQ has already licensed media to Axol Bioscience, partnered with MyoPalate, and earned backing from PRiME and Medicine by Design.
Let’s Get In Touch!
At boutIQ solutions Inc, we are transforming how custom cell culture media is developed, using powerful AI/ML to drive faster and smarter biological discovery. We’re excited to explore new horizons together!